Designing cell- and gene-based regeneration strategies to repair the injured spinal cord

Journal of Neurotrauma

Volumn 23, Issue 3-4, 2006, Pages 438-452

  Pearse, Damien Daniel ^a   Bunge, M B ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Axonal regeneration; Cell based therapies; Gene based therapies; Grafting; Spinal cord injury

Indexed keywords

CHEMOATTRACTANT;

ADOPTIVE IMMUNOTHERAPY; CELL FUNCTION; CELL MIGRATION; CELL TRANSPLANTATION; CELL TRANSPORT; EX VIVO STUDY; GENE DELIVERY SYSTEM; GENE THERAPY; GRAFT REJECTION; HUMAN; MYELINATION; NERVE FIBER REGENERATION; NERVE REGENERATION; NONHUMAN; REVIEW; SPINAL CORD INJURY;

EID: 33646572511     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2006.23.437     Document Type: Review

References (128)

1. AKIYAMA, Y., RADTKE, C., HONMOU, O., and KOCSIS, J.D. (2002). Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 39, 229-236.
2. BAKSHI, A., HUNTER, C., SWANGER, S., LEPORE, A., and FISCHER, I. (2004). Minimally invasive delivery of stem cells for spinal cord injury: advantages of the lumbar puncture technique. J. Neurosurg. Spine. 1, 330-337.
3. BAMBER, N.I., LI, H., LU, X., OUDEGA, M., AEBISCHER, P., and XU, X.M. (2001). Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur. J. Neurosci. 13, 257-268.
4. BARAKAT, D.J., GAGLANI, S.M., NERAVETLA, S.R., et al. (2005). Survival, integration and axon growth support of glia transplanted into the chronically contused spinal cord. Cell Transplant. 14, 225-240.
5. BARNETT, S.C., and RIDDELL, J.S. (2004). Olfactory ensheathing cells (OECs) and the treatment of CNS injury: advantages and possible caveats. J. Anat. 204, 57-67.
6. BAUMGARTNER, B.J., and SHINE, H.D. (1997). Targeted transducdon of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J. Neurosci. 17, 6504-6511.
7. BAVETTA, S., HAMLYN, P.J., BURNSTOCK, G., LIEBERMAN, A.R., and ANDERSON, P.N. (1999). The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. Exp. Neurol. 158, 382-393.
8. BEHRMANN, D.L., BRESNAHAN, J.C., BEATTIE, M.S., and SHAH, B.R. (1992). Spinal-cord injury produced by consistent mechanical displacement of the cord in rats behavioral and histologic analysis. J. Neurotrauma. 9, 197-217.
9. BERRY, M., CARLILE, J., and HUNTER, A. (1996). Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve. J. Neurocytol. 25, 147-170.
10. BERRY, M., GONZALEZ, A.M., CLARKE, W., et al. (2001). Sustained effects of gene-activated matrices after CNS injury. Mol. Cell Neurosci. 17, 706-716.
11. BLAKEMORE, W.E. (1976). Invasion of Schwann cells into the spinal cord of the rat following local injections of lysolecithin. Neuropathol. Appl. Neurobiol. 2, 21-39.
12. BLESCH, A., LU, P., and TUSZYNSKI, M.H. (2002). Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res. Bull. 57, 833-838.
13. BLESCH, A., and TUSZYNSKI, M.H. (2003). Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J. Comp. Neurol. 467, 403-417.
14. BLITS, B., BOER, G.J., and VERHAAGEN, J. (2002). Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration. Cell Transplant. 11, 593-613.
15. BLITS, B., OUDEGA, M., BOER, G.J., BUNGE, M.B., and VERHAAGEN, J. (2003). Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function. Neuroscience 118, 271-281.
16. BLOMER, U., NALDINI, L., VERMA, I.M., TRONO, D., and GAGE, F.H. (1996). Applications of gene therapy to the CNS. Hum. Mol. Genet. 5, 1397-1404.
17. BONADIO, J. (2000). Tissue engineering via local gene delivery. J. Mol. Med. 78, 303-311.
18. BOULIS, N.M., NOORDMANS, A.J., SONG, D.K., et al. (2003). Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery. Neurobiol. Dis. 14, 535-541.
19. BREGMAN, B.S., COUMANS, J.V., DAI, H.N, et al. (2002). Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog. Brain Res. 137, 257-273.
20. BUNGE, M.B. (2001). Bridging areas of injury in the spinal cord. Neuroscientist 7, 325-339.
21. BUNGE, M.B., and WOOD, P.M. (2006). Transplantation of Schwann cells and olfactory ensheathing cells to promote regeneration in the CNS, in: Textbook of Neural Repair and Rehabilitation. M.E. Selzer, S. Clarke, L.G. Cohen, P.W. Duncan, and F.H. Gage (eds), Cambridge University Press: Cambridge, pp. 513-531.
22. BURGER, C., NASH, K., and MANDEL, R.J. (2005). Recombinant adeno-assocaited viral vectors in the nervous system. Hum. Gene. Ther. 16, 781-791.
23. CAI, D., QIU, J., CAO, Z., McATEE, M., BREGMAN, B.S., and FILBIN, M.T. (2001). Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J. Neurosci. 21, 4731-4739.
24. CAO, Q., BERTON, R.L, and WHITTEMORE, S.R. (2002a). Stem cell repair of central nervous system injury. J. Neurosci. Res. 68, 501-510.
25. CAO, Q.L., ONIFER, S.M., and WHITTEMORE, S.R. (2002b). Labeling stem cells in vitro for identification of their differentiated phenotypes after grafting into the CNS. Methods Mol. Biol. 198, 307-318.
26. CAO, Q.L., HOWARD, R.M., DENNISON, J.B., and WHITTEMORE, S.R. (2002c). Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp. Neurol. 177, 349-359.
27. CAO, Q., XU, X.M., DEVRIES, W.H., et al. (2005). Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin- expressing glial-restricted precursor cells. J. Neurosci. 25, 6947-6957.
28. CAPLEN, N.J. (2004). Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Gene Ther. 11, 1241-1248.
29. CHUAH, M.I., and WEST, A.K. (2002). Cellular and molecular biology of ensheathing cells. Microsc. Res. and Tech. 58, 216-227.
30. CLARK, P.R., and HERSH, E.M. (1999). Cationic lipid-mediated gene transfer: current concepts. Curr. Opin. Mol. Ther. 1, 158-176.
31. ENZMANN, G.U., BENTON, R.L., TALBOTT, J.F., CAO, Q., WHITTEMORE, S.R. (2006). Functional considerations of stem cell transplantation therapy for spinal cord repair. J. Neurotrauma. 23, 479-495.
32. FEHLINGS, M.G., and TATOR, C.H. (1995). The relationships among the severity of spinal- cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal-cord injury. Exp. Neurol. 132, 220-228.
33. FOUAD, K., SCHNELL, L., BUNGE, M.B., SCHWAB, M.E., LIEBSCHER, T., and PEARSE, D.D. (2005). Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J. Neurosci. 25, 1169-1178.
34. FRISEN, J., HAEGERSTRAND, A., FRIED, K., PIEHL, F., CULLHEIM, S., and RISLING, M. (1994). Adhesive/repulsive properties in the injured spinal cord: relation to myelin phagocytosis by invading macrophages. Exp. Neurol. 129, 183-193.
35. FUJIWARA, Y., TANAKA, N., ISHIDA, O., et al. (2004). Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci. Lett. 366, 287-291.
36. GABRYEL, B., and TRZECIAK, H.I. (2001). Role of astrocytes in pathogenesis of ischemic brain injury. Neurotox. Res. 3, 205-221.
37. GAO, Y., DENG, K., HOU, J., et al. (2004). Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo. Neuron. 44, 609-621.
38. GEISERT, E.E., JR., DEL MAR, N.A., OWENS, J.L., and HOLMBERG, E.G. (1995). Transfecting neurons and glia in the rat using pH-sensitive immunoliposomes. Neurosci. Lett. 184, 40-43.
39. GELLER, H.M., and FAWCETT, J.W. (2002). Building a bridge: engineering spinal cord repair. Exp. Neurol. 174, 125-136.
40. GLORIOSO, J.C., and FlNK, D.J. (2004). Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annu. Rev. Microbiol. 58, 253-271.
41. GLORIOSO, J.C., GOINS, W.F., MEANEY, C.A., FINK, D.J., and DELUCA, N.A. (1994). Gene transfer to brain using herpes simplex virus vectors. Ann. Neurol. 35, S28-S34.
42. GOLDBERG, J.L., KLASSEN, M.P., HUA, Y., and BARRES, B. A. (2002). Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 296, 1860-1864.
43. GRILL, R., MURAI, K., BLESCH, A., GAGE, F.H., and TUSZYNSKI, M.H. (1997). Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci. 17, 5560-5572.
44. GROSSMAN S.D., ROSENBERG, L.J., and WRATHALL, J.R. (2001). Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp. Neurol. 168, 273-282.
45. GRUNER, J.A. (1992). A monitored contusion model of spinal-cord injury in the rat. J. Neurotrauma 9, 123-128.
46. HALL, E.D., and SPRINGER, I.E. (2004). Neuroprotection and acute spinal cord injury: a reappraisal. J. Am. Soc. Exp. Neurother. 1, 80-100.
47. HAN, S.S., LIU, Y., TYLER-POLSZ, C., RAO, M.S., and FISCHER, I. (2004). Transplantation of glial-restricted precursor cells into the adult spinal cord: survival, glial-specific differentiation, and preferential migration in white matter. Glia 45, 1-16.
48. HARVEY, A.R. (2000). Labeling and identifying grafted cells, in: Neural Transplantation Methods. S.B. Dunnet, A.A. Boulton, and G.B. Baker (eds), Humana Press: Totowa, NJ, pps. 319-361.
49. HARVEY, A.R., FAN, Y., BEILHARZ, M.W., and GROUNDS, M.D. (1992). Survival and migration of transplanted male glia in adult female mouse brains monitored by a Y-chromosome-specific probe. Brain Res. Mol. Brain Res. 12, 339-343.
50. HAUBEN, E., GOTHILF, A., COHEN, A., et al. (2003). Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J. Neurosci. 23, 8808-8819.
51. HENDRIKS, W.T., RUITENBERG, M.J., BLITS, B., BOER, G.J., and VERHAAGEN, J. (2004). Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog. Brain Res. 146, 451-476.
52. HILL, C.E., BEATTIE, M.S., and BRESNAHAN, J.C. (2001). Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat. Exp. Neurol. 171, 153-169.
53. HILL, C.E., PROSCHEL, C., NOBLE, M., et al. (2004). Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration. Exp. Neurol. 190, 289-310.
54. HILL, C.E., MOON, L.D., WOOD, P.M., and BUNGE, M.B. (2006). Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement and strategies to enhance survival. Glia. 53, 338-343.
55. HOULE, J.D., and TESSLER, A. (2003). Repair of chronic spinal cord injury. Exp. Neurol. 182, 247-260.
56. IWASHITA, Y., CRANG, A.J., and BLAKEMORE, W.F. (2000). Redistribution of bisbenzimide Hoechst 33342 from transplanted cells to host cells. Neuroreport. 11, 1013-1016.
57. JAKEMAN, L.B., and REIER, P.J. (1991). Axonal projections between fetal spinal cord transplants and the adult rat spinal cord: a neuroanatomical tracing study of local interactions. J Comp. Neurol. 307, 311-334.
58. JIN, Y., FISCHER, I., TESSLER, A., and HOULE, J.D. (2002). Transplants of fibroblasts genetically modified to express BDNF promote axonal regeneration from supraspinal neurons following chronic spinal cord injury. Exp. Neurol. 177, 265-275.
59. KEYVAN-FOULADI, N., RAISMAN, G., and LI, Y. (2003). Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J. Neurosci. 23, 9428-9434.
60. KLEITMAN, N. (2004). Keeping promises: translating basic research into new spinal cord injury therapies. J. Spinal Cord Med. 27, 311-318.
61. KOCSIS, J.D., AKIYAMA, Y., and RADTKE, C. (2004). Neural precursors as a cell source to repair the demyelinated spinal cord. J. Neurotrauma 21, 441-449.
62. KOBAYASHI, N.R., FAN, D.P., GIEHL, K.M., BEDARD, A.M., WIEGAND, S.J., and TETZLAFF, W. (1997). BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J. Neurosci. 17, 9583-9595.
63. KRISHNAN, B.R. (1999). Interleukin-1 receptor antagonist gene therapy for arthritis. Curr. Opin. Mol. Ther. 1, 454-457.
64. KWON, B.K., LIU, J., OSCHIPOK, L., and TETZLAFF, W. (2002a). Reaxotomy of chronically injured rubrospinal neurons results in only modest cell loss. Exp. Neurol. 177, 332-337.
65. KWON, B.K., OXLAND, T.R., and TETZLAFF, W. (2002b). Animal models used in spinal cord regeneration research. Spine 27, 1504-1510.
66. LEE, T.H., YANG, L.C., CHOU, A.K., et al. (2003). In vivo electroporation of proopiomelanocortin induces analgesia in a formalin-injection pain model in rats. Pain 104, 159-167.
67. LEE, Y.S., SINDHU, R.K., LIN, C.Y., EHDAIE, A., LIN, V.W., and VAZIRI, N.D. (2004). Effects of nerve graft on nitric oxide synthase, NAD(P)H oxidase, and antioxidant enzymes in chronic spinal cord injury. Free Radic. Biol. Med. 36, 330-339.
68. LI, Y., FIELD, P.M., and RAISMAN, G. (1997). Repair of adult rat corticospinal tract by transplants of olfactory ensheathing transplants. Science 277, 2000-2002.
69. LU, K.W., CHEN, Z.Y., JIN, D.D., HOU, T.S., CAO, L., and FU, Q. (2002). Cationic liposome-mediated GDNF gene transfer after spinal cord injury. J. Neurotrauma 19, 1081-1090.
70. LU, P., YANG, H, JONES, L.L., FILBIN, M.T., and TUSZYNSKI, M.H. (2004). Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J. Neurosci. 24, 6402-6409.
71. LU, P., JONES, L.L., and TUSZYNSKI, M.H. (2005). BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp. Neurol. 191, 344-360.
72. MADSEN, J.R., MACDONALD, P., IRWIN, N., et al. (1998). Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 154, 673-683.
73. MARTIN, D., ROBE, P., FRANZEN, R., et al. (1996). Effects of Schwann cell transplantation in a contusion model of rat spinal cord injury. J. Neurosci. Res. 45, 588-597.
74. McGEE, A.W., and STRITTMATTER, S.M. (2003). The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci. 26, 193-198.
75. MOON, L., and BUNGE, M.B. (2005). From animal models to humans: strategies for promoting CNS axon regeneration and recovery of limb function after spinal cord injury. J. Neurol. Phys. Ther. 29, 55-69.
76. NALDINI L., BLOMER, U., GALLAY, P., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
77. NAMIKI, J., KOJIMA, A., and TATOR, C.H. (2000). Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats. J. Neurotrauma 17, 1219-1231.
78. NIKULINA, E., TIDWELL, J.L., DAI, H.N., BREGMAN, B.S., and FILBIN, M.T. (2004). The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc. Natl. Acad. Sci. USA 101, 8786-8790.
79. OHTA, M., SUZUKI, Y., NODA, T., et al. (2004). Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol. 187, 266-278.
80. OKA, S., HONMOU, O., AKIYAMA, Y., et al. (2004). Autologous transplantation of expanded neural precursor cells into demyelinated monkey spinal cord. Brain Res. 1030, 94-102.
81. OUDEGA, M., and HAGG, T. (1996). Nerve growth factor promotes regeneration of sensory axons into adult rat spinal cord. Exp. Neurol. 140, 218-229.
82. OUSMAN, S.S., and DAVID, S. (2001). MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J. Neurosci. 21, 4649-4656.
83. PEARSE, D.D., MARCILLO, A.E., OUDEGA, M., LYNCH, M.P., WOOD, P.M., and BUNGE, M.B. (2004a). Transplantation of Schwann cells and olfactory ensheathing glia after spinal cord injury: does pretreatment with methylprednisolone and interleukin-10 enhance recovery? J. Neurotrauma 21, 1223-1239.
84. PEARSE, D.D., PEREIRA, F.C., MARCILLO, A.E., et al. (2004b). cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat. Med. 10, 610-616.
85. PEARSE, D.D., LO, T., Jr., CHO, K.S., et al. (2005). Histopathological and behavioral characterization of a novel cervical spinal cord displacement contusion injury in the rat. J. Neurotrauma 22, 680-702.
86. PELTEKIAN, E., PARRISH, E., BOUCHARD, C., PESCHANSKI, M., and LISOVOSKI, F. (1997). Adenovirus-mediated gene transfer to the brain: methodological assessment. J. Neurosci. Methods. 71, 77-84.
87. PLANT, G.W., CHRISTENSEN, C.L., OUDEGA, M., and BUNGE, M.B. (2003). Delayed transplantation of olfactory ensheathing glia promotes sparing/regeneration of supraspinal axons in the contused adult rat spinal cord. J. Neurotrauma 20, 1-16.
88. POPOVICH, P.G., WEI, P., and STOKES, B.T. (1997). Cellular inflammatory responses after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377, 443-464.
89. RAMÓN-CUETO, A., PLANT, G.W., AVILA, J., and BUNGE, M.B. (1998). Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J. Neurosci. 18, 3803-3815.
90. RAMON-CUETO, A., CORDERO, M.I., SANTOS-BENITO, F.F., and AVILA, J. (2000). Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25, 425-435.
91. RAPALINO, O., LAZAROV-SPIEGLER, O., AGRANOV, E., et al. (1998). Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4, 814-821.
92. REIER, P.J. (2004). Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx 1, 424-451.
93. RIBOTTA, M.G., PROVENCHER, J., FERABOLI-LOHNHERR, D., ROSSIGNOL, S., PRIVAT, A., and ORSAL, D. (2000). Activation of locomotion in adult chronic spinal rats is achieved by transplantation of embryonic raphe cells reinnervating precise lumbar level. J. Neurosci. 20, 5144-52.
94. ROMERO, M.I., and SMITH, G.M. (1998). Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade. Gene Ther. 5, 1612-1621.
95. ROMERO, M.I., RANGAPPA, N., GARRY, M.G., and SMITH, G.M. (2001). Functional regeneration of chronically injured sensory afferents into adult spinal cord after neurotrophin gene therapy. J. Neurosci. 21, 8408-8416.
96. ROSSI, F., BRAVIN, M., BUFFO, A., FRONTE, M., SAVIO, T., and STRATA, P. (1997). Intrinsic properties and environmental factors in the regeneration of adult cerebellar axons. Prog. Brain Res. 114, 283-296.
97. RUITENBERG, M.J., EGGERS, R., BOER, G.J., and VERHAAGEN, J. (2002). Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system. Methods 28, 182-194.
98. RUITENBERG M.J., PLANT G.W., HAMERS P.P., et al. (2003). Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J. Neurosci. 23, 7045-7058.
99. RUITENBERG, M.J., BLITS, B., DIJKHUIZEN, P.A., et al. (2004). Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury. Neurobiol. Dis. 15, 394-406.
100. SCHEFF, S.W., RABCHEVSKY, A.G., and FUGACCIA, I. (2003). Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179-193.
101. SENIOR, J.H., TRIMBLE, K.R., and MASKIEWICZ, R. (1991). Interaction of positively-charged liposomes with blood: implications for their application in vivo. Biochim. Biophys. Acta 1070, 173-179.
102. SHEA, L.D., SMILEY, E., BONADIO, J., and MOONEY, D.J. (1999). DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 117, 551-554.
103. SHI, L., TANG, G.P., GAO, S.J., et al. (2003). Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord. Gene Ther. 10, 1179-1188.
104. SILVER, S., and MILLER, J.H. (2004). Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146-166.
105. STORER, P.D., and HOULE, J.D. (2003). Beta II-tubulin and GAP 43 mRNA expression in chronically injured neurons of the red nucleus after a second spinal cord injury. Exp. Neurol. 183, 537-547.
106. TAKAMI, T., OUDEGA, M., BATES, M.L., WOOD, P.M., KLEITMAN, N., and BUNGE, M.B. (2002). Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J. Neurosci. 22, 6670-6681.
107. TATOR, C.H., and FEHLINGS, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
108. TENG, Z.P., CHEN, J., CHAU, L.Y., GALUNIC, N., and REGAN R.F. (2004). Adenoviral transfer of the heme oxygenase-1 gene protects striatal astrocytes from heme-mediated oxidative injury. Neurobiol. Dis. 17, 179-187.
109. TOBIAS, C.A., SHUMSKY, J.S., SHIBATA, M., et al. (2003). Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp. Neurol. 184, 97-113.
110. TOBIAS, C.A., HAN, S.S., SHUMSKY, J.S., et al. (2005). Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression. J. Neurotrauma 22, 138-156.
111. TUSZYNSKI, M.H., PETERSON, D.A., RAY, J., BAIRD, A., NAKAHARA, Y., and GAGE, F.H. (1994). Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp. Neurol. 126, 1-14.
112. VAN ESSEVELDT, K.E., HERMENS, W.T., VERHAAGEN, J., and BOER, G.J. (1997). Transgene expression in rat fetal brain grafts is maintained for 7 months after ex vivo adenoviral vector-mediated gene transfer. Neurosci. Lett. 240, 116-120.
113. VERHAAGEN, J., HERMENS, W.T., DIJKHUIZEN, P.A., HOLTMAAT, A.J., and GISPEN, P.A. (1995-96). Use of viral vectors to promote neuroregeneration. Clin. Neurosci. 3, 275-283.
114. VOLTERRA, A., TROTTI, D., TROMBA, C., FLORIDI, S., and RACAGNI, G. (1994). Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
115. WANG, K.C., KIM, J.A., SIVASANKARAN, R., SEGAL, R., and HE, Z. (2002). P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420, 74-78.
116. WEISS, B., DAVIDKOVA, G., and ZHOU, L.W. (1999). Antisense RNA gene therapy for studying and modulating biological processes. Cell. Mol. Life Sci. 55, 334-358.
117. WHITTEMORE, S.R., ZHANG, Y.P., SHIELDS, C.B., MORASUTTI, D.J., and MAGNUSON, D. (2002). Optimizing stem cell grafting into the CNS. Methods Mol. Biol. 198, 319-325.
118. WILSON, J.X. (1997). Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75, 1149-1163.
119. WIRTH, E.D., REIER, P.J., FESSLER., et al. (2001). Feasibility and safety of neural tissue transplantation in patients with syringomyelia. J. Neurotrauma 18, 911-929.
120. WONG, S.T., HENLY, J.R., KANNING, K.C., HUANG, K.H., BOTHWELL, M., and POO, M.M. (2002). A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 5, 1302-1308.
121. WRATHALL, J.R., PETTEGREW, R.K., and HARVEY, F. (1985). Spinal cord contusion in the rat: production of graded, reproducible, injury groups. Exp. Neurol. 88, 108-122.
122. WU, P., YE, Y., and SVENDSEN, C.N. (2002). Transduction of human neural progenitor cells using recombinant adenoassociated viral vectors. Gene Ther. 9, 245-255.
123. WU, C.M., LIN, M.W., CHENG, J.T., et al. (2004). Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats. Gene Ther. 11, 933-940.
124. XU, X.M., GUENARD, V., KLEITMAN, N., AEBISCHER, P., and BUNGE, M.B. (1995). A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp. Neurol. 134, 261-272.
125. XU, X.M., CHEN, A., GUENARD, V., KLEITMAN, N., and BUNGE, M.B. (1997). Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. J. Neurocytol. 26, 1-16.
126. YOUNG, W. (2002). Spinal cord contusion models. Prog. Brain Res. 137, 231-255.
127. ZHANG, Y., DIJKHUIZEN, P.A., ANDERSON, P.N., LIEBERMAN, A.R., and VERHAAGEN, J. (1998). NT-3 delivered by an adenoviral vector induces injured dorsal root axons to regenerate into the spinal cord of adult rats. J. Neurosci. Res. 54, 554-562.
128. ZHANG, G., and SELZER, M.E. (2001). In vivo transfection of lamprey brain neurons by gene gun delivery of DNA. Exp. Neurol. 167, 304-311.